Egle Therapeutics is a France-based biotechnology company that develops regulatory T-cell immunotherapies for the treatment of cancer and autoimmune diseases.
Business Model:
Revenue: $1.8M
Employees: 11-50
Address: 29 Rue du Faubourg St Jacques
City: Paris
State: île-de-france
Zip: 75014
Country: FR
Egle Therapeutics is a France-based biotechnology company that develops regulatory T-cell immunotherapies for the treatment of cancer and autoimmune diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2021 | Series A | $46.6M |
LSP Management Group B.V. bpifrance FUND+ Bioqube Ventures Takeda Ventures, Inc. |
10/2021 | Series A | $0 |
Bioqube Ventures Bpifrance Fund+ Life Sciences Partners Takeda Ventures Bioqube Ventures Bpifrance Fund+ Life Sciences Partners Takeda Ventures |
10/2021 | Series A | 5 | $46.6M |
Bioqube Ventures Bpifrance Fund+ Life Sciences Partners Takeda Ventures Bioqube Ventures Bpifrance Fund+ Life Sciences Partners Takeda Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|